1 We have studied the role of nitric oxide (NO) in the regulation of the transcellular biosynthesis of sulphidopeptide leukotrienes (cys-LT) generated upon neutrophil-vascular wall interactions and their functional consequences, in the spontaneously beating, cell-perfused, heart of the rabbit. 2 Hearts were perfused under recirculating conditions (50 ml) with 5610 6 puri®ed human neutrophils (PMNL), and challenged with 0.5 mM A-23187 for 30 min. Coronary perfusion pressure (CPP) and leftventricular end-diastolic pressure (LVEDP) were monitored. Cys-LT formation was measured by reversed phase high performance liquid chromatography (h.p.l.c.) and u.v. spectral analysis. Myeloperoxidase (MPO) enzyme activity, assayed in aliquots of the recirculating buer, was used as a marker of PMNL adhesion to the coronary endothelium. 3 Basal CPP and LVEDP values averaged 45+1.4 mmHg and 5+0.1 mmHg, respectively; A-23187 triggered an increase in CPP (134+9 mmHg, at 30 min) which was signi®cantly attenuated by pretreatment with L-arginine, 100 mM (90+3 mmHg, at 30 min). Pretreatment with N G -monomethyl-Larginine, 10 mM (L-NMMA), induced a marked increase in CPP (290+40 mmHg, at 20 min) and in LVEDP (47+16 mmHg), so pronounced that it caused cardiac arrest in systole in 5 out of 6 hearts and these were prevented by L-arginine, 100 mM (CPP 115+10 mmHg, LVEDP 6+1.1 mmHg, at 30 min). 4 The increase in CPP was accompanied by the release of cys-LT in the circulating buer, which was reduced signi®cantly by L-arginine. Pretreatment with L-NMMA, caused a marked rise in cys-LT concentrations which was prevented by L-arginine. 5 Neither L-arginine nor L-NMMA aected directly the A-23187-induced arachidonic acid (AA) metabolism in isolated PMNL alone. 6 Pretreatment with L-NMMA caused a prompt drop in myeloperoxidase (MPO) activity, suggesting rapid adhesion of PMNL to the coronary wall; this eect was signi®cantly blunted by L-arginine. 7 This study suggests that NO provides cardioprotection in an organ model of transcellular metabolism of cys-LT by preventing PMNL adhesion to the coronary intima.
Introduction
Adhesion of polymorphonuclear leukocytes (PMNL) to vascular endothelial cells is a characteristic feature of in¯amma-tion (Grant, 1973) ; endothelial cells and neutrophils express adhesion proteins which mediate cell ± cell interactions and regulate the transmigration of PMNL across the vascular endothelial barrier into the tissues, where they are involved in the immune response (Carlos & Harlan, 1994) . Nitric oxide (NO), is a powerful, biologically active autacoid, which is formed by vascular endothelium and rapidly inactivated by superoxide (Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986) . NO has been recently identi®ed as a multifunctional mediator, produced by, and acting on, most cells of the body. Besides its function as a relaxing factor, a neurotransmitter and an immune defence molecule (Ignarro, 1990; Moncada et al., 1991) , there is accumulating evidence that NO participates in the inhibition of platelet aggregation (Radomski et al., 1987a) and adhesion to endothelial monolayers (Radomski et al., 1987b) as well as in the prevention of PMNL activation (McCall et al., 1988) . These latter properties of NO may be of relevance in ischaemia-reperfusion damage where PMNL play a key role in the propagation of reperfusion injury (Mullane, 1988) and where NO donors have been shown to exert a signi®cant antiadherence eect on PMNL (Lefer, 1992 ). The precise mechanism by which NO exerts these eects remains unde®ned. However, endogenous NO appears to play a signi®cant role in inhibiting PMNL adherence to the endothelium in postcapillary venules, possibly via suppression of CD11/CD18 expression on PMNL (Kubes et al., 1991) .
The microenvironment located at the interface between PMNL and vascular endothelial cells seems therefore to represent a strategic site which regulates the interplay between these cell populations. Pharmacological interventions which alter one or more factors involved in such cell ± cell cross-talk, may have important repercussions in the control of vascular bed (e.g. in the coronaries) reactivity and function, representing a fundamentally important therapeutic target. Recently, the concept of inter-cellular cooperation, in the handling of unstable intermediates of eicosanoid biosynthesis (transcellular biosynthesis), has attracted a considerable interest. Original work of Marcus et al. (1980) has clearly shown that platelets cooperate with endothelial cells in the formation of prostacyclin (PGI 2 ) and similarly neutrophils interact with platelets as well as endothelial cells in generating sulphidopeptide leukotrienes (cys-LT) (Feinmark & Cannon, 1986; Maclouf & Murphy, 1988) . The formation of cys-LT by cell ± cell cooperation has been shown to cause a marked coronary vaso-constriction accompanied by severe morphological inammatory changes in the rabbit heart (Sala et al., 1993; 1996a) .
In light of these ®ndings, the importance of NO as a regulatory factor of cell-cell interaction, as well as of transcellular biosynthesis of cys-LT has been investigated in a model of PMNL-perfused rabbit heart. Moreover the capacity of nitric oxide to interfere with alterations of coronary tone and heart mechanics has been studied.
Methods
Hearts from male albino rabbits (BMG-Allevamento, Cividate al Piano, BG, Italy) weighing 2.5 ± 2.8 kg, were isolated and perfused retrogradely through the aorta, as previously described (Berti et al., 1988; Sala et al., 1993) , with Krebs Henseleit solution (mM: NaCl 137, KCl 4.0, CaCl 2 2.0, NaH 2 PO 4 1.8, MgCl 2 1.8, NaHCO 3 25 and glucose 5.5), areated with a gas mixture (95% O 2 +5% CO 2 ) and kept at 378C. Perfusion rate was maintained at 20 ml min 71 by a roller pump (GilsonMinipulse 2, Biolabo, Milan, Italy). A latex balloon was inserted into the left ventricular cavity for measurement of left ventricular end-diastolic pressure (LVEDP), recorded with a Hewlett Packard (Waltham, MA, U.S.A.) carrier ampli®er (model 8805B) and recorder (model 7754A). The balloon was slowly ®lled with saline, to stabilize LVEDP at 5 mmHg. Hearts were equilibrated for 30 min and ®nally perfused in a recirculating system (50 ml); coronary perfusion pressure (CPP) and LVEDP were monitored continuously. Rabbit hearts were perfused with puri®ed human neutrophils (PMNL), isolated from human blood (40 ml), withdrawn from healthy donors who had not received medications for at least 1 week and collected in 5.7 ml of ACD (citric acid monohydrate 41 mM; Na-citrate dihydrate 100 mM and glucose 136 mM). PMNL were obtained by dextran T-500 sedimentation (3% w/ v in saline to a ®nal 1.22%) of platelet rich plasma (PRP)-deprived human blood; erythrocytes were lysed and a Ficoll solution (Ficoll-Paque, Pharmacia) layered under the cell suspension and spun for PMNL puri®cation (400 g for 30 min at room temperature).
PMNL (5610 6 cells) suspension was supplied with Ca 2+ (2 mM) and Mg 2+ (0.5 mM) immediately before heart perfusion, diluted to 5 ml in Tyrode solution and added, at a¯ow rate of 0.6 ml min 71 to avoid mechanical obstruction, to 45 ml of the recirculating medium. A 15 min stabilization period, under recirculating conditions, was allowed before treatment with L-arginine (100 mM) or N G -monomethyl-L-arginine (L-NMMA; 10 mM). When both L-arginine and L-NMMA were used, a 10 min interval was left between treatments; 10 min later, the PMNL suspension was added to the reservoir¯uid. Challenge with A-23187 (0.5 mM) was performed 10 min after PMNL infusion and lasted for 30 min. At the end of the experiment, the entire heart reservoir¯uid was withdrawn for storage under argon atmosphere at 7208C until high-performance liquid chromatography (h.p.l.c.) analysis.
Cell incubation
PMNL (5610 6 ml 71 in 1 ml PBS) were supplied with Ca 2+ (2 mM) and Mg 2+ (0.5 mM) and incubated for 5 min at 378C before addition of L-arginine (100 mM) and/or L-NMMA (10 mM); 10 min later, PMNL were challenged with A-23187, 0.5 mM, for 30 min. Stimulation was stopped by addition of ice-cold methanol (1 ml) and samples were stored at 7208C until analysis as previously described (Rossoni et al., 1996) .
H.p.l.c. analysis
The entire heart reservoir¯uid (approx. 45 ml) was collected, spiked with 50,000 d.p.m. After centrifugation at 3,500 g for 15 min, 5 ml of phosphate buer 1 M, pH 7.4 were added and the sample extracted by use of a solid phase cartridge (Mega Bond-Elut C8, Varian, Harbor City, CA, U.S.A.). The cartridge was washed with 5 ml of hexane and eluted ®rst with 4 ml of ethylacetate : methanol (99 : 1) and then with 4 ml of methanol : water (90 : 10). The ethyl acetate fractions, containing PGB 2 and the dihydroxyarachidonic acid derivative LTB 4 , were dried, reconstituted in 0.6 ml of solvent A (methanol/acetonitrile/water/acetic acid, 10 : 10 : 80 : 0.02, v : v : v : v, pH 5.5 with ammonium hydroxide) and injected into an h.p.l.c. gradient pump system (Beckman mod. 126) connected to a diode array u.v. detector (Beckman mod. 168). U.v. absorbance was monitored at 280 nm, and full u.v. spectra (210 ± 340 nm) acquired at a rate of 0.5 Hz. A multilinear gradient from solvent A to solvent B (50% methanol, 50% acetonitrile) was used. This method allows easy separation of LTB 4 from both 5S,12S-dihydroxy eicosatetraenoic acid (5S,12S-diHETE) and D6 trans LTB 4 epimers. The dried methanolic extracts, containing sulphidopeptide leukotrienes only, were reconstituted in h.p.l.c. solvent A (0.6 ml) containing 25 ng of PGB 2 ; radioactivity was measured with a b-counter (Packard mod. 4000, Milan, Italy) to assess recovery of cys-LT (40 ± 70%). The remaining sample was injected into the same h.p.l.c. system used for LTB 4 . The use of [ 3 H]-LTD 4 to monitor recovery was necessary because of the double extraction protocol used. Positive identi®cation of cys-LT was obtained through u.v. spectral analysis of chromatographic peaks eluting at characteristic retention times. Quantitation was performed on positively identi®ed peaks only, with standard curves of synthetic LTC 4 /D 4 /E 4 and LTB 4 (Cascade Biochem., Reading, UK) and values of cys-LT were corrected for recovery.
MPO assay
Myeloperoxidase (MPO) was used as a marker enzyme for measuring PMNL adhesion. Aliquots (1 ml) of the buer recirculating through the isolated hearts were withdrawn at dierent time intervals and centrifuged at 12,000 g (2 min). The supernatant was carefully removed and cell pellets resuspended in 200 ml phosphate buer, 50 mM, pH 6.0, containing 0.5%, w : v, hexamethyltetrammonium bromide (HTAB) and 0.1%, w : v, gelatine. Samples, kept on ice, were then sonicated in 4 cycles (15 s per cycle) and ®nally centrifuged at 13,000 g (15 min).
MPO activity was assayed in the supernatant by measuring the H 2 O 2 -dependent oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) (Suzuki et al., 1983) . The reaction was performed in a 96-wells microtitre plate; the reaction mixture consisted of 25 ml sample or MPO standard, 25 ml of a 16 mM solution of TMB in DMSO and 200 ml of 0.375 mM H 2 O 2 in 0.08 M phosphate buer, pH 5.4. This mixture was incubated for 5 min at 378C and the reaction blocked by the addition of 25 ml of a 13.6 mg ml 71 solution of bovine catalase. In its oxidized form, TMB has a blue color, which was measured spectrophotometrically at 620 nm.
Drugs
Human MPO, L-arginine hydrochloride, L-NMMA, bovine catalase, HTAB, TMB were from Sigma-Aldrich (Milan, Italy). PGB 2 , LTC 4 , LTD 4 , LTB 4 were from Cayman Chemical (Ann Arbor, MI, U.S.A.).
Statistics
In all experiments, dierences between control and treated groups were analysed for statistical signi®cance by a one-way analysis of variance (ANOVA) and Student's t test (two-tailed) for unpaired samples as appropriate. A value of P50.05 was accepted as signi®cant.
In all tables and ®gures, results are expressed as mean+ s.e.mean.
Results

Eect on CPP
The rabbit isolated hearts, perfused under basal recirculating conditions at a constant¯ow of 20 ml min 71 for 30 min demonstrated an average CPP of 45+1.4 mmHg; resistance to perfusion pressure did not change when unstimulated human PMNL (5610 6 cells) were perfused through the rabbit isolated heart. However, challenge with the calcium ionophore A-23187 (0.5 mM) in the presence of PMNL, brought about a signi®cant increase in CPP which started approximately 10 min after challenge and continued thereafter (Figure 1) . Pre-challenge LVEDP values were 5+0.1 mmHg and increased to 11.7+6.7 mmHg after challenge with A-23187 in the presence of PMNL. Pretreatment (30 min before challenge) of the rabbit hearts with L-arginine (100 mM) did not aect coronary tone but resulted in a signi®cant protection against the PMNL-dependent increase (Figure 1) . Pretreatment (20 min before challenge) of the rabbit hearts with L-NMMA (10 mM) caused a progressive increase in CPP which was slow in onset and unaected by A-23187 (0.5 mM) (Figure 2 ). When L-NMMA-treated hearts were challenged in the presence of PMNL, a marked increase in CPP was seen, which was fast in onset and so pronounced as to cause cardiac arrest in systole in 5 out of 6 hearts at 20 min (Figure 2 ). LVEDP also increased markedly to 47+16 mmHg (P50.01 vs control PMNL).
The striking increase in CPP observed in the presence of L-NMMA was fully prevented by L-arginine (Figure 3 ). L-Arginine pretreatment was also able to prevent the increase in LVEDP at 30 min after A-23187 challenge of recirculating PMNL; in fact, LVEDP values observed under these conditions were not dierent from pre-challenge values (6+1 mmHg, P50.01 vs L-NMMA).
Leukotriene production of the PMNL-perfused isolated heart of rabbit H.p.l.c. analysis of the ®nal volume of the recirculating perfusate showed that, in the absence of PMNL, cys-LT (LTC 4 -LTD 4 ) were almost undetectable (Figure 2) . However, when challenge with A-23187 was carried out in the presence of PMNL, formation of cys-LT took place and allowed their positive identi®cation by on-line u.v. spectrum analysis ( Figure  1) ; following pretreatment with L-arginine, the amount of cys-LT detected in the perfusion buer was signi®cantly reduced (Figure 1) .
Pretreatment of the rabbit hearts with L-NMMA, followed by challenge with A-23187 in the presence of PMNL, led to a two fold increase in cys-LT formation compared to untreated hearts (Figures 1 and 2) , which was fully inhibited by L-arginine (Figure 3 ).
Cell incubation experiments
Challenge of puri®ed human PMNL with A-23187 (0.5 mM for 30 min) resulted in the expected generation of LTB 4 as well as of its metabolites (20-hydroxy-and 20-carboxy-LTB 4 ), collectively referred to as LTBs. Trivial amounts of cys-LT were also detected, probably due to the presence of eosinophils in the PMNL preparation (Figure 4) . Pretreatment of human PMNL with L-arginine, L-NMMA or their combination, did not interfere with the neutrophil metabolic pathway of arachidonic acid (AA).
Dynamics of recirculating PMNL in rabbit perfused heart
We evaluated myeloperoxidase enzyme activity (MPO) in aliquots (1 ml) of the recirculating buer, taken at dierent time intervals, as an index of PMNL adhesion to the intima of the ) and challenged with A-23187 (0.5 mM) (~; n=6), or challenged with A-23187 in the absence of PMNL (^; n=3), or challenged with vehicle (ethanol) (^; n=3). Cys-LT were analysed by reverse-phase h.p.l.c. after extraction of whole buer reservoir¯uid, withdrawn 30 min after challenge. Values are mean+s.e.mean; s.e.mean are not shown when smaller than symbols. *P50.05; **P50.01; ***P50.001 vs PMNL-perfused heart. drop of MPO activity was slower in onset and signi®cantly less pronounced, indicating the persisting presence of PMNL in the recirculating buer ( Figure 5) .
Moreover, none of the hearts (n=3) treated with L-NMMA alone, survived till 30 min after challenge, whereas all the hearts (n=4) treated with L-NMMA+L-arginine survived more than 30 min after A-23187 challenge.
Discussion
We have shown that pharmacological modulation of the NO pathway can markedly aect the cooperation between PMNL and coronary endothelial cells, in a model of rabbit PMNLperfused heart, resulting in altered transcellular biosynthesis of sulphidopeptide leukotrienes and coronary tone. The present investigation follows previous studies in which we showed that challenge of PMNL, adhering to the coronary vascular wall, was accompanied by profound vasoconstriction and perivascular oedema, parallel to the formation of cys-LT, measured as LTC 4 and LTD 4 (Sala et al., 1996a) . The eects observed could not be reproduced by simple addition of high amounts (2 mg) of exogenous LTC 4 , given as a bolus injection (personal unpublished observations), indicating the primary importance of local concentrations of cys-LT acting on target cells at the site of production, in good agreement with their autacoid nature. In this respect PMNL are cells which seem to be intended for transcellular biosynthesis of cys-LT, since a substantial proportion of their primary AA metabolites, i.e. the unstable epoxide leukotriene A 4 (LTA 4 ), is released outside the cells, where it becomes available to neighbouring acceptor cells (e.g. endothelial cells, EC) for further metabolism (Sala et al., 1996b) . This could lead to high local bioavailability of cys-LT which are known to constrict coronary arteries (Michelassi et al., 1982) and have vasopermeant properties (Dahlen et al., 1981) by contributing to endothelial cell retraction phenomena. This might have relevance for the extravasation of white cells from the vessel lumen to the tissue.
The interaction between PMNL and EC is controlled by a variety of factors that regulate the tracking and migration of leukocytes. Both cells express on their surface pro-adhesive molecules, with diverse structures and mechanisms of expression, which may act as receptors to tether the two cells together or as signals that induce activation-dependent adhesion events (Zimmermann et al., 1992) . Less is known about locally produced factors that exert an inhibitory in¯uence on leukoycte adhesion.
In recent years nitric oxide has attracted considerable interest as part of a widespread intercellular communication system. Two isoforms of NO synthase, the constitutive and the inducible enzyme, synthesize NO in the vascular system, by the stereospeci®c removal of the guanido nitrogen atom of L-arginine (White & Marletta, 1992) . Endothelial cells possess the constitutive enzyme but are also able to express the inducible form by the action of bacterial products and/or cytokines (Rees et al., 1990) . Continuous generation of NO has been shown to play an important role in setting the resting tone of systemic as well as coronary resistance vessels (Huang et al., 1995) ; in addition NO exerts several other eects including inhibition of PMNL activation and adherence (McCall et al., 1989) . These properties may be of considerable importance in explaining the modulatory role of NO on the transcellular biosynthesis of cys-LT, taking place between PMNL and coronary endothelial cells. Inhibition of NO synthesis resulted in an expected increase in coronary tone (Amezcua et al., 1989) , in a marked worsening of the PMNLdependent and cys-LT-dependent coronary vasoconstriction as well as in enhanced biosynthesis of cys-LT. This was competitively antagonized by pretreatment with exogenous Larginine, without direct action on either coronary perfusion pressure or 5-lipoxygenase enzyme activity. This indicates that the cardioprotective eect of NO is not simply restricted to the control of the coronary vascular tone, but may reside in its capacity to modulate the cross-talk between circulating cells and vessel wall. Increased adhesion of PMNL to the endothelium has been found following treatment with L-NMMA (Herbaczynska-Cedro et al., 1991; Kubes et al., 1994) , and it is therefore plausible to hypothesize that under these conditions a facilitated transfer of LTA 4 might take place between donor cells (PMNL) and acceptor cells (coronary EC), where it becomes available for metabolism by the LTC 4 -synthase. The protection observed in the presence of L-arginine, is in line with previous ®ndings, showing signi®cant anti-adherence eects (Kubes et al., 1991; Lefer, 1992) and prevention of integrin-induced PMNL adhesion to postischaemic venules (Kubes et al., 1994) .
The rapid disappearance of MPO enzyme activity that we observed in the circulating buer following L-NMMA treatment, compared to its persistence in the presence of L-arginine, con®rms the proposed role of nitric oxide as an endogenous modulator of PMNL adhesion. The exact mechanism linking inhibition of NO production with increased PMNL adherence is still unde®ned and may involve superoxide formation and mast cell activation (Kubes et al., 1993) .
The biological role of NO in controlling vascular homeostasis may be potentially relevant in the pathogenesis of vascular diseases such as human coronary atherosclerosis, where the capacity of the endothelium to synthesize NO is reduced, or cardiac infarction and ischaemia-reperfusion injury, where PMNL are active participants in propagating tissue damage (Schmid-Schonbein, 1993 ) and increased urinary leukotriene excretion has been obtained (Carry et al., 1992) . Research directed at the prophylactic use of agents which are able to prevent the adhesion of PMNL to the vascular endothelium and to cut o the biochemical interplay between these two cell populations, may prove eective in reducing the incidence of ischaemic heart disease and myocardial infarction.
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